쿼드메디슨

464490· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

₩4,160+2.59%

2026-11-02

Financials

Valuation Metrics

쿼드메디슨's Market Cap is ₩479B. At end of 2025 it was ₩1794B. Ranked #1755 of 2,410 in KR market (top 73%), #1065 of 1,631 on KOSDAQ (top 65%), #186 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 81%) by Market Cap.

Investment Metrics(as of 2026-11-02)

Metric	Value	Rank
Size
Market Cap	47.87B KRW	KR#1,755/2,410 Sec#186/231
Revenue	7.14B KRW	KR#2,305/2,410 Sec#184/231
Net Income	-10.11B KRW	KR—/2,410 Sec—/231
Total Assets	48.75B KRW	KR#2,214/2,410 Sec#203/231
Net Assets	24.55B KRW	KR#2,228/2,410 Sec#207/231
Value
P/B	1.95x	KR#1,962/2,410 Sec#145/231
P/S	6.70x	KR#2,219/2,410 Sec#151/231
FCF Yield	-14.07%	KR—/2,410 Sec—/231
Profitability
ROE	-41.18%	KR#2,239/2,410 Sec#190/231
ROA	-20.74%	KR#2,241/2,410 Sec#178/231
Op. Margin	-137.93%	KR#2,309/2,410 Sec#180/231
Revenue Growth	14.99%	KR#684/2,410 Sec#64/231
Financial Health
Debt Ratio	98.59%	KR#1,545/2,410 Sec#177/231
Total Debt	7.80B KRW	KR#1,688/2,410 Sec#155/231
FCF	-6.74B KRW	KR#1,575/2,410 Sec#128/231
Cash	8.16B KRW	KR#1,799/2,410 Sec#160/231
Current Ratio	1.58x	KR#1,124/2,410 Sec#122/231
Performance
1M Return	-19.22%	KR#1,528/2,410 Sec#154/231
From 52W High	-84.68%	KR#2,362/2,410 Sec#223/231
1Y MDD	-83.95%	KR#2,335/2,410 Sec#217/231
Trading
Volume	8,445 shares	KR#1,518/2,410 Sec#154/231
Trading Value	34.5M KRW	KR#1,560/2,410 Sec#163/231
Foreign Own.	4.22%	KR#997/2,410 Sec#90/231
Per Share
EPS	-878 KRW	KR—/2,410 Sec—/231
BPS	2,133 KRW	KR#2,051/2,410 Sec#169/231